SCHEMBL16639765

SCHEMBL16639765

O=C(NCc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cc2cccc(Br)c2o1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 7/20 0.62
MAPK1 P28482 1/20 0.55
LMNA P02545 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
ALOX15 P16050 1/20 0.52
HSD17B10 Q99714 1/20 0.52
CNR2 P34972 1/20 0.52
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.50
ALDH1A1 P00352 1/20 0.50
FGB P02675 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
THRB P10828 1/20 0.50
PABPC1 P11940 1/20 0.50
PPARG P37231 1/20 0.50
NCOA2 Q15596 1/20 0.50
NCOA1 Q15788 1/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16639803 0.84 NAMPT (0.75) NAMPTMAPK1LMNASMN1; SMN2ALOX15
SCHEMBL15246137 0.77 NAMPT (1.00) NAMPT
SCHEMBL16639772 0.77 NAMPT (0.76) NAMPTMAPK1LMNASMN1; SMN2ALOX15
SCHEMBL16639759 0.76 NAMPT (0.73) NAMPTSMN1; SMN2KMT2AALDH1A1
SCHEMBL16639802 0.75 NAMPT (0.75) NAMPTSMN1; SMN2KMT2AALDH1A1MAPT
SCHEMBL16644181 0.74 NAMPT (0.76) NAMPTMAPK1LMNASMN1; SMN2ALOX15
SCHEMBL15246491 0.74 NAMPT (0.57) NAMPTMAPK1LMNASMN1; SMN2ALOX15
SCHEMBL15246471 0.73 SMN1; SMN2 (0.58) NAMPTMAPK1LMNASMN1; SMN2ALOX15
SCHEMBL16639784 0.72 NAMPT (0.65) NAMPTMAPK1LMNASMN1; SMN2ALOX15
SCHEMBL15246332 0.72 NAMPT (0.67) NAMPTMAPK1LMNASMN1; SMN2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES VALO HEALTH, INC. 2015-04-16 US disclosed
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES VALO HEALTH, INC. 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150104384-A1 AMIDO-BENZYL SULFONE AND SULFOXIDE DERIVATIVES STS, SULT1E1, CBS NAMPT 759/4885MAPK1 3941/4885LMNA 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.